Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More
The Gait-O-Gram can detect and analyze gait information from an individual and, through the use of fuzzy logic algorithms, determine the presence of neuromuscular symptoms. More
We have technology to produce chiral intermediates of high quality by biotransformation More
Recently characterized MUC17 gene highly specific for pancreatic cancer. More
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
An siRNA type therapeutics delevary system More
precise and focused control of temperature mediated therapy and “triggering” deliverables in situ. More
Novel agents capable of reaching remote cellular sites More
Related Reports
Market Research Reports provided by reports.innovaro.com
Mar 2011 - 5 pages - $500
Jul 2011 - 36 pages - $3,800
Feb 2011 - 209 pages - $3,500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Nov 2010 - 50 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us